See more : QXO Inc (QXO) Income Statement Analysis – Financial Results
Complete financial analysis of Lagis Enterprise Co., Ltd. (6730.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lagis Enterprise Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Be Shaping The Future S.p.A. (BEST.MI) Income Statement Analysis – Financial Results
- Gardiner Healthcare Acquisitions Corp. (GDNRU) Income Statement Analysis – Financial Results
- Br. Holdings Corporation (1726.T) Income Statement Analysis – Financial Results
- PlayWay S.A. (PLW.WA) Income Statement Analysis – Financial Results
- Aequi Acquisition Corp. (ARBG) Income Statement Analysis – Financial Results
Lagis Enterprise Co., Ltd. (6730.TWO)
About Lagis Enterprise Co., Ltd.
Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. Its products include trocars, single port surgery devices, and wound protectors; endo devices, such as hand instruments and advanced bipolar devices; specimen retrieval products; suction irrigation systems and irrigation pumps; training systems; and related accessories. The company was founded in 1993 and is headquartered in Taichung, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 459.93M | 442.19M | 393.04M | 319.36M | 406.53M |
| Cost of Revenue | 241.05M | 219.31M | 214.76M | 180.68M | 189.05M |
| Gross Profit | 218.89M | 222.88M | 178.28M | 138.68M | 217.49M |
| Gross Profit Ratio | 47.59% | 50.40% | 45.36% | 43.42% | 53.50% |
| Research & Development | 58.93M | 62.00M | 47.91M | 40.44M | 36.67M |
| General & Administrative | 51.96M | 52.87M | 44.92M | 34.83M | 42.43M |
| Selling & Marketing | 30.89M | 26.33M | 20.62M | 18.81M | 26.06M |
| SG&A | 82.85M | 79.20M | 65.55M | 53.64M | 68.48M |
| Other Expenses | 0.00 | 1.41M | 644.00K | 545.00K | 0.00 |
| Operating Expenses | 141.79M | 141.20M | 113.46M | 94.07M | 106.00M |
| Cost & Expenses | 382.83M | 360.51M | 328.22M | 274.75M | 295.05M |
| Interest Income | 566.00K | 217.00K | 42.00K | 160.00K | 192.00K |
| Interest Expense | 68.00K | 124.00K | 120.00K | 199.00K | 226.00K |
| Depreciation & Amortization | 32.17M | 31.87M | 31.01M | 27.23M | 24.19M |
| EBITDA | 112.36M | 120.58M | 92.31M | 67.82M | 136.52M |
| EBITDA Ratio | 24.43% | 27.30% | 23.49% | 21.22% | 33.58% |
| Operating Income | 77.10M | 88.84M | 61.30M | 40.53M | 112.33M |
| Operating Income Ratio | 16.76% | 20.09% | 15.60% | 12.69% | 27.63% |
| Total Other Income/Expenses | 3.03M | 6.91M | -3.64M | -4.22M | -878.00K |
| Income Before Tax | 80.13M | 88.59M | 61.18M | 40.40M | 111.45M |
| Income Before Tax Ratio | 17.42% | 20.03% | 15.57% | 12.65% | 27.42% |
| Income Tax Expense | 16.03M | 17.55M | 12.24M | 8.07M | 22.29M |
| Net Income | 64.11M | 71.04M | 48.94M | 32.32M | 89.16M |
| Net Income Ratio | 13.94% | 16.06% | 12.45% | 10.12% | 21.93% |
| EPS | 2.00 | 2.22 | 1.53 | 1.01 | 2.86 |
| EPS Diluted | 1.98 | 2.18 | 1.52 | 1.01 | 2.84 |
| Weighted Avg Shares Out | 32.00M | 32.00M | 32.00M | 32.00M | 31.17M |
| Weighted Avg Shares Out (Dil) | 32.43M | 32.57M | 32.29M | 32.11M | 31.39M |
Source: https://incomestatements.info
Category: Stock Reports